Skip to main content

Featured

Carney Tempers Expectations on U.S.-Canada Trade Talks

                                             Carney says U.S. tariff reprieve 'unlikely' to happen before CUSMA review talks. Canadian Prime Minister Mark Carney has downplayed the likelihood of a near-term trade deal between Canada and the United States, signaling that any progress will likely be folded into the upcoming review of the Canada-U.S.-Mexico Agreement (CUSMA) scheduled for 2026. Speaking at a press conference in Ottawa, Carney explained that efforts to secure sector-specific agreements—particularly in industries such as steel, aluminum, autos, and lumber—have stalled since U.S. President Donald Trump abruptly ended negotiations in October. The talks were derailed after Ontario aired a controversial anti-tariff advertisement featuring former President Ronald Reagan, which drew sharp criticism from Washington. Carney emphasized that while Canada...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment